Andrij Parekh Directs Netflix's 'The Retrievals': What the IVF Scandal Series Signals About Streaming's Long Bet on Procedural Prestige

On 8 July 2026, Variety reported that Emmy-winning director Andrij Parekh — best known for his work on HBO's Succession — is set to direct two episodes of Netflix's upcoming limited series The Retrievals, written and executive produced by Molly Smith Metzler, creator of Maid. The series adapts the real-life scandal at a Yale fertility clinic, in which a nurse replaced patients' pain medication with saline during egg-retrieval procedures. Parekh's attachment, announced as the project moves toward production, links one of prestige television's most-cinematic visual stylists to a story whose emotional core is institutional betrayal rather than dynastic backroom politics.

The booking is the kind of personnel decision that rarely makes headlines on its own and yet quietly sets the tonal ceiling for a multi-million-dollar production. Parekh's Succession episodes — including the series' long-take-heavy kitchen confrontation and its hushed boardroom sequences — established a visual register that treated corporate malfeasance as something almost liturgical, lit like Old Master canvases and scored in deadpan piano. The Retrievals offers a different canvas: a medical institution whose abuse of trust was, in its particulars, banal — a nurse with a fentanyl dependency swapping vials — but whose consequences for patients were anything but. The visual challenge is to dignify that banality without aestheticising it.

A procedural with a procedurally difficult subject

The Yale case, which surfaced publicly in 2024 through a cluster of patient accounts and reporting by The New York Times Magazine, centred on a nurse who admitted to diverting fentanyl meant for egg-retrieval patients and replacing it with saline. Hundreds of women underwent procedures at the clinic believing they were receiving sedation they did not in fact receive; subsequent civil litigation and regulatory review followed. The case became a touchstone in reproductive-medicine journalism, in part because the patient cohort — women enduring the physical and financial strain of IVF — was already operating under documented medical trauma when the new harm was inflicted.

Metzler's involvement, established before Parekh's attachment, signals a writerly interest in institutional failure told through the perspective of those it failed. Her previous work on Maid — itself drawn from a memoir of domestic abuse and bureaucratic indigence — turned a procedural eligibility fight into a study of how systems grind against the people they nominally serve. The pairing of Metzler's lean, character-driven prose with Parekh's formalism is the kind of behind-the-camera calibration that streamers increasingly use to differentiate limited-series bets from the procedural-and-procedural clutter of cable reruns.

For Netflix, the calculus is partly about prestige and partly about adjacency. The platform has spent the better part of two years publicly recalibrating its scripted strategy: linear-style weekly dramas, once the foundational pitch to subscribers, now compete with talk-show-format comedies, international co-productions, and live-event programming for greenlight oxygen. Limited series drawn from ripped-from-the-headlines health or legal scandals remain one of the formats where the streamer can credibly pitch awards-adjacent craft while holding to a fixed episode count that disciplines budget overruns. The Retrievals, on paper, slots neatly into that category.

What Parekh's visual signature does — and doesn't — solve

Parekh's prestige runs deeper than Succession. The Ukrainian-born director has logged episodes of Station Eleven, Devs, and The OA — series whose visual signatures depend less on plot momentum than on the slow accumulation of mood. His reputation is for letting shots sit, for treating production design and natural light as moral weather. In Succession, the camera's reluctance to cut during the company's most consequential meetings became the show's quiet thesis: that power, when you can stand to look at it, is almost always boring.

The risk of carrying that approach into The Retrievals is straightforward. A series about patients discovering, sometimes years after the fact, that their bodies were lied to during moments of acute vulnerability demands a register that is neither clinical nor operatic. The material carries its own gravity; an over-aestheticised treatment risks turning real patients into set decoration. A flat, procedural treatment, by contrast, risks underplaying the cumulative weight of hundreds of individual discoveries that the institutional story has to hold. Parekh's track record suggests he will resolve this tension by trusting silence — letting a patient sit with a chart in her hand rather than cutting to a reaction shot — but the answer is not yet on screen.

The market context: prestige limited series as a streaming hedge

Industry analysts have spent much of 2025 and the first half of 2026 arguing that prestige drama's economics are stretched. The numbers vary by methodology, but the pattern is consistent: weekly episode-of-the-week dramas have lost ground to formats with stronger completion-rate signals, and the prestige limited series — eight to ten episodes, a fixed arc, awards-friendly cast — has emerged as a residual category where streamers still write large cheques. The Retrievals sits inside that residual category, with the additional wrinkle that it adapts a story that was already journalism rather than memoir or novel. That distinction matters because legal clearances on real-patient stories have grown more exacting; the show's production will need not only patient consent but the kind of structural accuracy that holds up under the inevitable documentary comparison.

For Netflix, the upside is dual. A prestige execution could plausibly contend in limited-series categories at the Emmys, where the streamer has historically been more successful with limited formats (When They See Us, Unbelievable) than with ongoing dramas. The subject matter — fertility, pain, institutional failure — also indexes into audience pockets the streamer has been quietly cultivating through documentaries and limited series that blend advocacy and entertainment. The downside is the downside of any ripped-from-the-headlines bet: the moment a real patient disputes a characterisation, the show's own credibility becomes part of the story.

What remains unresolved

Several questions hang over the project that the Parekh announcement does not resolve. The casting of the central patient cohort, the nurse antagonist, and the institutional defenders has not yet been detailed publicly. The episode order, beyond Parekh's two, is also unsettled in public reporting. And the show's release window — a meaningful variable in any awards calculus — has not been pinned to a date. Each of these variables will shape whether The Retrievals lands as a prestige event or as one more entry in the growing catalogue of healthcare-scandal adaptations whose best intentions do not always translate into best-in-class execution.

What is clear is that Netflix continues to bet on the format. In a streaming economy where every scripted greenlight competes with talk formats, live events, and international co-productions, a limited series about a real IVF scandal, helmed by a director whose visual signature has been refined across three of the past decade's most discussed dramas, is the kind of bet the platform still knows how to place. Whether the bet pays off in attention, awards, or cultural durability is the question the production itself, not the announcement, will answer.

— Monexus Staff Writer. This desk note sits inside the body per editorial protocol; the byline is rendered from frontmatter.

Wire provenance

This editorial synthesis draws on the following public wire/social posts:

• https://en.wikipedia.org/wiki/The_Retrievals_(TV_series)